Peptides for Under-Eye Circles and Bags: The Ingredient Guide

The under-eye area is one of the first places to show visible aging, fatigue, and poor health — and it responds well to targeted peptide intervention when the right ingredients are matched to the right underlying causes. Dark circles, puffiness, and fine lines under the eyes each have distinct mechanisms, and the peptides that address them work through fundamentally different pathways.

This guide is structured as an ingredient reference: what each major peptide does, the evidence supporting it, and which under-eye concern it best addresses. Not every ingredient is appropriate for everyone — the right protocol depends on identifying your primary concern.

Understanding the Under-Eye Problem: Multiple Causes, Multiple Solutions

Before reaching for any ingredient, identify your dominant concern:

Dark circles may be caused by pigmentation (melanin in the epidermis, common in darker skin tones), vascular visibility (thin skin allowing blue-purple veins to show through), shadowing from under-eye hollowing, or post-inflammatory pigmentation. Each cause responds to different treatments.

Under-eye bags (puffiness) result from fat herniation through weakened orbital septum, fluid accumulation (lymphatic sluggishness or allergies), or both. Structural fat herniation requires procedural intervention; fluid-based puffiness responds to topical ingredients.

Fine lines and crepey texture stem from loss of collagen, elastin, and hyaluronic acid in the extremely thin under-eye skin (the thinnest on the face at 0.5mm, compared to 2mm elsewhere).

Hollowing and volume loss reflect loss of subcutaneous fat and collagen — addressing this with topicals is challenging; hyaluronic acid filler is the most effective intervention here.

Eyeseryl: The Fluid-Puffiness Specialist

Eyeseryl (acetyl tetrapeptide-5) is the most studied peptide for under-eye puffiness specifically. Its primary mechanism is reducing glycation-induced edema — a process where sugars bind to proteins in the extracellular matrix, causing tissue swelling through osmotic effects. It also improves lymphatic drainage by strengthening capillary walls, reducing plasma protein leakage into the surrounding tissue.

A published clinical trial by Lintner et al. demonstrated that a formulation containing 10% Eyeseryl reduced under-eye bags by an average of 20% compared to placebo after 28 days of twice-daily application. The peptide works specifically on the fluid component of puffiness — it cannot address structural fat herniation through a weakened orbital septum.

Eyeseryl is typically found in specialist eye cream formulations at 0.1–1% concentrations. It should be applied to the orbital bone area with gentle tapping motions (not rubbing, which increases fluid movement) and is best used morning and evening. It works well in combination with caffeine, which provides additional vasoconstriction for immediate visible depuffing.

GHK-Cu: Structural Repair and Dark Circle Reduction

Copper tripeptide GHK-Cu addresses multiple under-eye concerns through different mechanisms:

Skin thickening: By stimulating collagen I, III, and elastin synthesis, GHK-Cu thickens the extremely thin under-eye skin. Thicker skin means vessels and discoloration show through less vividly — directly addressing vascular dark circles. Over several months, consistent use can produce measurable increases in under-eye skin density.

Angiogenesis modulation: GHK-Cu has context-dependent effects on blood vessel formation. In the under-eye context, it helps strengthen existing capillaries, reducing leakage of red blood cells into surrounding tissue (where hemoglobin breakdown produces bluish pigmentation — a contributor to some dark circles).

Anti-inflammatory action: Chronic inflammation around the eye contributes to both dark circles and puffiness. GHK-Cu reduces TNF-α and IL-6 in a manner relevant to the orbital area.

The under-eye skin is very thin and absorptive — use GHK-Cu at low concentrations (0.5–1%) and apply only a small amount to the orbital bone (avoid the waterline). Our comprehensive GHK-Cu skin guide includes guidance on concentration, formulation, and combining it safely with other actives.

Argireline: Relaxing Repetitive Movement Lines

Argireline (acetyl hexapeptide-3 or acetyl hexapeptide-8) is a synthetic peptide that inhibits SNARE complex formation — the protein assembly that allows nerve terminals to release acetylcholine, triggering muscle contraction. By reducing neurotransmitter release, Argireline produces a mild muscle-relaxing effect similar in concept to botulinum toxin, though far more modest in magnitude.

For the under-eye area, the relevant application is the reduction of expression lines from squinting — the crow's feet at the outer corners and the fine lines that form with repeated contraction of the orbicularis oculi muscle. These are dynamic lines, and Argireline's effect is most pronounced on frequently-used expression lines rather than static wrinkles that persist at rest.

Clinical evidence for Argireline is largely funded by manufacturer Lipotec, which limits independence of the data. However, a published study in International Journal of Cosmetic Science (2002) showed 17% reduction in wrinkle depth after 30 days at 10% concentration. Most consumer products contain 2–5% — likely below the effective threshold, but often insufficient to match the study results.

For maximum efficacy, Argireline requires concentrations of 5–10%. It should be applied before heavier moisturizers so it can absorb into the epidermis, and not combined with vitamin C (ascorbic acid) which may oxidize adjacent peptides in unstable formulations.

Snap-8: Enhanced Argireline with Extended Duration

Snap-8 (acetyl octapeptide-3) is an 8-amino-acid extension of Argireline that targets a broader site on the SNARE complex, potentially producing a more complete inhibition of neurotransmitter release. The developer (Lipotec) positions it as approximately double the efficacy of Argireline at equal concentrations.

Independent clinical data on Snap-8 are limited — much of the published evidence comes from manufacturer studies. Mechanistically, its SNARE-inhibition approach is sound, and the molecular length that allows it to interact with additional SNARE complex sites is well-characterized.

In practice, many premium eye creams contain both Argireline and Snap-8 as a complementary pair targeting slightly different aspects of the SNARE complex. There is no known interaction between the two. Concentration remains important — look for Snap-8 listed in the first half of the ingredient list to ensure meaningful dosing.

Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7 (Matrixyl 3000)

The Matrixyl 3000 combination — palmitoyl tripeptide-1 (pal-GHK) and palmitoyl tetrapeptide-7 (pal-GQPR) — addresses structural fine lines and loss of dermal integrity in the under-eye area through collagen synthesis stimulation.

Palmitoyl tripeptide-1 mimics collagen breakdown fragments, signaling fibroblasts to produce replacement collagen. Palmitoyl tetrapeptide-7 reduces inflammatory cytokine production (particularly IL-6 and IL-8) that degrades the extracellular matrix. Together, they represent the signal peptide approach to under-eye rejuvenation — less targeted than Argireline for expression lines, but addressing the structural loss that makes the under-eye area look hollowed and crepey.

A published study by Lintner and Peschard (2000) using an ex vivo skin model demonstrated palmitoyl pentapeptide-4 (earlier Matrixyl) significantly increased collagen synthesis compared to control. Matrixyl 3000 builds on this with the additional anti-inflammatory tetrapeptide component.

Building a Complete Under-Eye Protocol

Morning under-eye routine:

1. Cool compress (1 minute) — reduces overnight fluid accumulation
2. Eyeseryl-containing eye serum or gel, applied by tapping on the orbital bone
3. Caffeine eye cream over the top (optional, for immediate depuffing)
4. SPF 30+ (UV damage is a major driver of under-eye aging — non-negotiable)

Evening under-eye routine:

1. Thorough makeup removal — residue accelerates under-eye irritation
2. GHK-Cu serum on orbital area and upper cheek
3. Matrixyl 3000 eye cream
4. On expression-line-focused nights (3–4x/week): apply Argireline/Snap-8 serum before the moisturizing step

For comprehensive anti-aging peptide layering beyond the eye area, see our guide on best peptides for anti-aging.

Frequently Asked Questions

Q: Can peptides eliminate genetic dark circles? Dark circles with a strong genetic component — particularly those in darker skin tones caused by excess melanin production — respond better to brightening ingredients (niacinamide, vitamin C, kojic acid) than to peptides. Peptides can help by thickening skin (GHK-Cu) but won't directly reduce melanin production. For melanin-driven dark circles, see our peptides for dark spots post.

Q: Is it safe to use Argireline around the eyes long-term? Long-term safety data for Argireline are reassuring — no evidence of dependency, rebound, or toxicity from cosmetic concentrations. It does not cause the muscle atrophy seen with repeated botulinum toxin injections at cosmetic concentrations. Patch testing on the inner arm before orbital application is sensible for first use.

Q: How close to the eye can I apply peptide products? Apply to the orbital bone — the bony ridge around the eye socket — rather than directly to the eyelid or waterline. Most peptide serums are not tested for direct ocular contact. If a product gets into the eye, rinse thoroughly with water.

Q: Why do most eye creams not contain enough active peptides to be effective? Eye creams are among the highest-margin cosmetic products. Formulation budgets often prioritize packaging and fragrance over ingredient load. The concentration of active peptides needed for efficacy (5–10% for Argireline, 0.5–2% for GHK-Cu, 0.1%+ for Eyeseryl) is achievable but not always profitable at retail price points. Look for products from evidence-driven brands that publish their concentrations.

Q: Can I use retinol and peptides in the same under-eye routine? Low-concentration retinol (0.025–0.05%) specifically formulated for the eye area can be used on alternating nights with peptide serums. Do not combine retinol and peptides in the same application — retinol may degrade some peptide bonds. Use peptides on some nights, retinol on others, and allow each to absorb fully before applying any occlusive moisturizer.